Form 4 for ABT Abbott Laboratories
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001415889-24-006405 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-03-01 | ABT | Earnhardt Lisa D | EVP | S - Sale | $118.50 | -694 | 84.3K | -0.8% | -$82.2K | |
| 2024-03-04 | 2024-02-29 | ABT | Earnhardt Lisa D | EVP | F - Tax | $120.05 | -7,669 | 85.0K | -8% | -$920.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-03-01 | S | D | 694 | $118.50 | 84,314 | D | — | — | |
| 2 | Common | Common shares without par value | 2024-02-29 | F | D | 7,669 | $120.05 | 85,008 | D | — | — |